Full Text View
Tabular View
No Study Results Posted
Related Studies
Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis
This study has been completed.
Study NCT00059449   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: April 25, 2003   Last Updated: November 15, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Necrotizing Enterocolitis
Premature Birth
Additional conditions recognized in this trial
Enterocolitis
Enterocolitis, Necrotizing
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Obstetric Labor Complications
Obstetric Labor, Premature
Pregnancy Complications
Additional drug interventions recognized in this trial
Mitogens
More general drug interventions related to this trial
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services